LS Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,275
Closed -$654K 795
2021
Q1
$654K Sell
4,275
-897
-17% -$137K 0.04% 315
2020
Q4
$808K Sell
5,172
-533
-9% -$83.3K 0.04% 305
2020
Q3
$653K Sell
5,705
-38
-0.7% -$4.35K 0.04% 318
2020
Q2
$645K Sell
5,743
-254
-4% -$28.5K 0.04% 312
2020
Q1
$538K Sell
5,997
-984
-14% -$88.3K 0.04% 310
2019
Q4
$755K Sell
6,981
-75
-1% -$8.11K 0.04% 367
2019
Q3
$691K Buy
7,056
+349
+5% +$34.2K 0.04% 363
2019
Q2
$878K Buy
6,707
+18
+0.3% +$2.36K 0.05% 305
2019
Q1
$904K Buy
6,689
+94
+1% +$12.7K 0.06% 290
2018
Q4
$642K Sell
6,595
-66
-1% -$6.43K 0.04% 340
2018
Q3
$926K Sell
6,661
-17
-0.3% -$2.36K 0.05% 308
2018
Q2
$829K Buy
6,678
+151
+2% +$18.7K 0.05% 326
2018
Q1
$727K Sell
6,527
-249
-4% -$27.7K 0.04% 366
2017
Q4
$810K Buy
6,776
+418
+7% +$50K 0.05% 335
2017
Q3
$892K Sell
6,358
-175
-3% -$24.6K 0.05% 301
2017
Q2
$795K Buy
6,533
+402
+7% +$48.9K 0.05% 325
2017
Q1
$743K Buy
6,131
+706
+13% +$85.6K 0.05% 320
2016
Q4
$664K Buy
5,425
+179
+3% +$21.9K 0.05% 326
2016
Q3
$643K Sell
5,246
-349
-6% -$42.8K 0.05% 323
2016
Q2
$653K Sell
5,595
-21
-0.4% -$2.45K 0.05% 335
2016
Q1
$782K Buy
5,616
+359
+7% +$50K 0.06% 267
2015
Q4
$1M Buy
5,257
+89
+2% +$17K 0.08% 228
2015
Q3
$808K Buy
5,168
+100
+2% +$15.6K 0.07% 248
2015
Q2
$916K Buy
5,068
+190
+4% +$34.3K 0.07% 234
2015
Q1
$845K Buy
4,878
+21
+0.4% +$3.64K 0.06% 252
2014
Q4
$899K Sell
4,857
-546
-10% -$101K 0.07% 223
2014
Q3
$896K Sell
5,403
-86
-2% -$14.3K 0.08% 211
2014
Q2
$858K Buy
5,489
+3
+0.1% +$469 0.07% 214
2014
Q1
$835K Buy
5,486
+2,644
+93% +$402K 0.07% 220
2013
Q4
$378K Buy
2,842
+1,905
+203% +$253K 0.03% 268
2013
Q3
$109K Buy
937
+263
+39% +$30.6K 0.01% 282
2013
Q2
$62K Buy
+674
New +$62K 0.01% 293